Thu, 18-Aug-2022
Thursday 30 Jan 2020 , 2:35 pm

3D Printing Revolutionizing Healthcare to Create Organs, Implants, and Medical Devices

3D printing technology is used by the healthcare sector to produce artificial organs for transplants, accelerate surgical procedures, and produce cheaper surgical tools. With continuous technological advancements, rise in the investments, and increased adaption on lab-scale and mass production platforms, the industry is expected to grow in future.
Share at:

Three-dimensional (3D) printing is a manufacturing technology that generates a physical product from digital information. Nowadays, this technology is used by the healthcare sector to produce artificial organs for transplants, accelerate surgical procedures, and produce cheaper surgical tools.

3D printing provides wide scope to develop artificial organs with advanced technology. When created manually, these parts needs significant amount of details and it takes lot of time and cost, plus there are chances of human error. This technology has enabled healthcare experts to make iterations before its printing and potential errors can be identified effortlessly.

With the technology, creators have options to make custom complex and organic shapes with different new composites and hybrid plastics to make lightweight products with improved strength. By selecting and combining the suitable materials, the products become more comfortable for patients.

Source: Website of Brinter

Recently, a 3D printing company called 3D Systems and CollPlant Biotechnologies, the developer of proprietary recombinant human collagen (rhCollagen) BioInk technology currently used for 3D bioprinting of tissues and organs, announced signing a joint development agreement. With this, two companies plan to develop tissue and scaffold bioprinting processes for third party collaborators.

On the Occasion, Chuck Hull, co-founder and chief technology officer, 3D Systems said, “We believe 3D printing to be a key technology for regenerative medicine, and this collaboration is one of many we are entering to play an integral role in this exciting field. Combining our innovative 3D printing technologies with CollPlant’s rhCollagen based BioInks has the potential to make a significant impact in bioprinting and regenerative medicine.”

A major challenge for the 3D printing manufacturers is to get an approval from healthcare regulators and this can affect the growth of the field. The U.S. Food and Drug Administration (FDA) is actively tracking the 3D printing industry very closely and it has also provided Technical Considerations for Additive Manufactured Medical Devices and Guidance for Industry its staff.

As per the report published by The Insight Partners, 3D printing medical devices market is expected to grow in future because of the continuous technological advancements, rise in the investments for research and developments, and increased adaption on lab-scale and mass production platforms.




Neha Mule

Neha writes articles on sectors including medicine, food, materials, and science & technology. A qualified statistician, she has the ability to observe and analyze the trends in global markets and write compelling articles that help CXOs in decision making. She is a bookworm and loves to read fiction, lifestyle, science and technology. Neha comes with 6 years of experience in content writing and editing that involves blog writing, preparation of study materials and OERs.

More from Neha Mule

Related News